Get started
Author

Gabriel Kremmidiotis

Neuronal Sodium-Channel α1-Subunit Mutations in Generalized Epilepsy with Febrile Seizures Plus
2001 · R.H. Wallace, I.E. Scheffer, et al. · The American Journal of Human Genetics · 343
Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease
2002 · Xiaoying Hou, Michal Mrug, et al. · Journal of Clinical Investigation · 240
Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease
2002 · Xiaoying Hou, Michal Mrug, et al. · Journal of Clinical Investigation · 189
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene
2004 · Kavita Bhalla, Hilary A. Phillips, et al. · Journal of Human Genetics · 146
Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties
2011 · Bernard L. Flynn, Gurmit S. Gill, et al. · Journal of Medicinal Chemistry · 144
Localization of Human Cadherin Genes to Chromosome Regions Exhibiting Cancer-Related Loss of Heterozygosity
1998 · Gabriel Kremmidiotis, Elizabeth Baker, et al. · Genomics · 84
BNC105: A Novel Tubulin Polymerization Inhibitor That Selectively Disrupts Tumor Vasculature and Displays Single-Agent Antitumor Efficacy
2010 · Gabriel Kremmidiotis, Annabell F. Leske, et al. · Molecular Cancer Therapeutics · 78
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
2002 · Marina Kochetkova, Olivia L D McKenzie, et al. · PubMed · 72
The Batten disease gene product (CLN3p) is a Golgi integral membrane protein
1999 · G Kremmidiotis · Human Molecular Genetics · 63
Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
2011 · Danny Rischin, David C. Bibby, et al. · Clinical Cancer Research · 62
ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription
2006 · Raman Kumar, Jantina Manning, et al. · Molecular Cancer Research · 56
Sequencing, Transcript Identification, and Quantitative Gene Expression Profiling in the Breast Cancer Loss of Heterozygosity Region 16q24.3 Reveal Three Potential Tumor-Suppressor Genes
2002 · Jason A. Powell, Alison E. Gardner, et al. · Genomics · 56
A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
2013 · Anna K. Nowak, Chris Brown, et al. · Lung Cancer · 54
Molecular and Functional Analyses of the Human and Mouse Genes Encoding AFG3L1, a Mitochondrial Metalloprotease Homologous to the Human Spastic Paraplegia Protein
2001 · Gabriel Kremmidiotis, Alison E. Gardner, et al. · Genomics · 50
Changes in CD44 Expression during B Cell Differentiation in the Human Tonsil
1995 · Gabriel Kremmidiotis, Heddy Zola · Cellular Immunology · 49
Genomic Structure and Complete Nucleotide Sequence of the Batten Disease Gene,CLN3
1997 · Hannah M. Mitchison, Patricia B. Munroe, et al. · Genomics · 46
A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis
2004 · Zhi-Jian Su, Christopher N. Hahn, et al. · Proceedings of the National Academy of Sciences · 45
PDF
Integration of Transcript and Genetic Maps of Chromosome 16 at Near-1-Mb Resolution: Demonstration of a “Hot Spot” for Recombination at 16p12
1995 · D.F. CALLEN, S.A. LANE, et al. · Genomics · 45
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
2015 · Sumanta Pal, Arun Azad, et al. · Clinical Cancer Research · 40
The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer
2014 · Daniel J Inglis, Tina C Lavranos, et al. · Cancer Biology & Therapy · 26
PDF
Expression profiling reveals functionally important genes and coordinately regulated signaling pathway genes during in vitro angiogenesis
2005 · C. N. Hahn, Z. J. Su, et al. · Physiological Genomics · 16
Aberrant CBFA2T3B gene promoter methylation in breast tumors.
2004 · Anthony J Bais, Alison E Gardner, et al. · Molecular Cancer · 16
PDF
Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease
2002 · Xiaoying Hou, Michal Mrug, et al. · Journal of Clinical Investigation · 14
PDF
Heterogeneity of CD44 expression among human B‐cell subpopulations
1998 · G. Kremmidiotis, J. Ridings, et al. · Tissue Antigens · 8
Abstract 2774: Anti-cancer activity of the tumor-selective, hypoxia-inducing, agent BNC105 in platinum resistant ovarian cancer
2012 · Tina C. Lavranos, Annabell F. Leske, et al. · Cancer Research · 6
Works count: 86
Citation count: 1,990
H-index: 20
I10-index: 23
Year
Topic
Type